Annovis Bio, Inc.ANVSNYSE
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+782.9%
5Y CAGR+375.0%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+782.9%/yr
vs +432.4%/yr prior
5Y CAGR
+375.0%/yr
Recent acceleration
Acceleration
+350.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2419x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$19.53B+185007.0%
2024$10.55M+83.4%
2023$5.75M-79.7%
2022$28.38M-37.9%
2021$45.69M+465.8%
2020$8.07M+434488.7%
2019$1858.00-94.7%
2018$35312.00-89.8%
2017$347472.00-